![]() Press Release Distribution |
Filter News Show All ResultsNews By Country
News By Tag Pwrm Ob ![]() Related Tags Acacia Research
Actg Bc-serapro Biomedical Dr. Ira L. Goldknopf Helen R. Park Ira L. Goldknopf Justin Handy Nuropro Otc:pwrm Otcbb:pwrm Parexel Penny To Buck Power 3 Medical Power 3 Medical Products Power3 Power3 Medical Power3 Medical Products Prxl Pwrm
| pwrm ob Latest News+ XML/RSSBy Karl McMahon Power3 has filed several patent applications for its NuroPro® technology that are currently pending. By Greg Lumpkin PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. InvestorsVoice Issues Trade Alert on PWRM.OB, ATV, ACTL, ACTS, - Power3 Medical Product, Acorn Inter By InvestorsVoice PWRM has filed several patent applications for its NuroPro technology that are currently pending. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases. By Karl McMahon Northrop Grumman Corporation (NYSE:NOC) announced the donation of a robust geospatial data set and capability to the Boy Scouts of America in support of their 100th anniversary and to help further scouting education. By Derrick Bosket PWRM has filed several patent applications for its NuroPro technology that are currently pending. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases. By Blayne Sheffield PWRM.OB, HMA, RDN, & NVE: NV Energy, Inc. Reports Third Quarter Earnings By Blayne Sheffield Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. NRO, ULU, SA, & PWRM.OB: Drills Upgrading Large Resource at Seabridge Gold's Courageous Lake Project By Blayne Sheffield NRO, ULU, SA, & PWRM.OB: Drills Upgrading Large Resource at Seabridge Gold's Courageous Lake Project By Pennytobuck.com Power3 Medical, PWRM.OB, China Lodging Group, HTHT, China Mass Media Corp, CMM, China Marine Food Group, CMFO - Growing Companies From PennytoBuck.com By Pennytobuck.com PWRM.OB, STV, CDII, DL Wall Street Stock Watch From PennytoBuck.com - Power3 Medical, China Digital TV Holding Co, China Direct Industries, China Distance Education Holdings By Pennytobuck.com Three Great Penny Stocks To Watch - Crown Equity Holdings, CRWE.OB, Proteonomix, PROT.OB, Power3 Medical, PWRM.OB By Pennytobuck.com PWRM.OB, WM, WAT, WSO Are On PennyToBuck's Stock Highlights for Sept. 27, 2010 By Pennytobuck.com Stock Alerts From Wall Street By PennytoBuck.com - Power3 Medical, PWRM.OB, WPO, WRE, WCN By Pennytobuck.com Companies On the Move Presented By PennytoBuck.com - Delivery Technology Solutions, Inc., DTSL.PK, Power3 Medical Products, PWRM.OB, UDR Inc, UDR, Ultra Petroleum Corp, UPL Happy Sunday News From PennytoBuck.com - Sturm, Ruger & Company,RGR, Power3 Medical Products,PWRM.OB By Pennytobuck.com Happy Sunday News From PennytoBuck.com - Sturm, Ruger & Company,RGR, Power3 Medical Products,PWRM.OB By Pennytobuck.com Wall Street Report From PennytoBuck.com - Power3 Medical, PWRM.OB, MUSCLEPHARM, MSLP.OB, Walgreens, WAG, Walmart, WMT By Lynnette Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases By Justin Handy Stock Update On PWRM, TAXS, USB for August 31st, 2010 from PennyToBuck.com By Justin Handy Stock Highlight On GENZ, PWRM, ENZ from PennytoBuck.com By Justin Handy PennyToBuck Stock Updates on PWRM, HLF, STEM for August 26th, 2010 By Hanson Power3 Medical Products (OTCBB: PWRM.OB) BC-SeraPro™ was developed and its performance characteristics determined by the Power3 Medical Products Laboratories. By Hanson PWRM BC-SeraPro was developed and its performance characteristics determined by the Power3 Medical Products Laboratories.BC-SeraPro™ is an ideal diagnostic test to evaluate breast cancer abnormalities By Hanson Power3 Medical Products (OTCBB: PWRM.OB) BC-SeraPro™ was developed and its performance characteristics determined by the Power3 Medical Products Laboratories. By Justin Handy MRK reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor. By Hanson With these results, PWRM’s NuroPro now extends into the pharmaceutical arena due to its ability to predict and monitor the response to drug treatment By Blayne Sheffield PWRM.OB, ILMN, & VSYM.OB: ILMN has recently reported the production of the Eco Real-Time PCR System By Hanson The Company is in a strong competitive position with over 190 identified biomarkers and a state-of-the-art proteomics laboratory. By Hanson BC-SeraPro™ could detect the disease at a point when treatment is more effective, less expensive, or both. By Hanson PWRM’s NuroPro was originally indicated for diagnostics to determine whether or not a patient had Alzheimer’s disease. By Blayne Sheffield PWRM, MNTA, & SNY: Raul E. Kohan will be appointed Chief Executive Officer By Justin Handy LLY stated that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling that that Gemzar's method-of-use patent is invalid. By Hanson Power3 Medical Products Inc., (OTCBB: PWRM.OB) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies By Justin Handy PWRM.ob has filed for patent protection for these findings and will be publishing these seminal results in the near future in one of the world’s most prestigious peer-reviewed scientific journals. By Blayne Sheffield MNTA, GENZ, & PWRM.OB: Biotech Stocks: Onyx, Genzyme, Momenta in spotlight By DrStockPick Power3 Medical Products, Inc. (OTCBB:PWRM.OB) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies. By DrStockPick Power3 Medical Products is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. By Blayne Sheffield GENZ, PWRM, & SNY: Blink on Friday And Miss Massive Biotech Spikes By Hanson PWRM’s NuroPro Blood Test is diagnostic tool for the early detection of Neurodegenerative diseases. By Blayne Sheffield PWRM, ILMN, & CAH: Sequenom Rises as Ladenburg Says Buy, Jefferies Starts at Hold By Hanson PWRM’s NuroPro was originally indicated for diagnostics to determine whether or not a patient had Alzheimer’s disease. By Blayne Sheffield AFFX, LIFE, & OTC:PWRM: Affymetrix Launches Axiom Custom Genotyping Arrays Utilizing World's Largest Validated SNP Database By Blayne Sheffield SNY, GSK, & OTC:PWRM: Weekly Pharma Roundup: GSK Settles, Vivus Disappoints, Ely Lilly Axes By ANTHONY BARTLEY Skymark Research, a leading provider of small- and micro-cap independent investment research initiated coverage on Power3 Medical Products, Inc. By Lynn Lansky Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, recently announced that Glucose RapidSpray, is now available under a trial run at selected Boots UK retail chain stores. Molecular Insight Receives Fifth Extension of Waiver Agreement with Bond Holders: MIPI, PWRM, & SIGA By Blayne Sheffield Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery. By Lynn Lansky Power3 Medical Products (OTCBB: PWRM.OB) business focus is the development of commercial applications for their proprietary technologies. By Lynn Lansky Power3 Medical Products (OTCBB: PWRM.OB) NuroPro Blood Test is diagnostic tool for the early detection of Neurodegenerative diseases. By Justin Handy PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. | ||||||||||||||||||||||